Soleo and Mitsubishi Tanabe Enter Data-sharing Agreement for Radicava
Mitsubishi Tanabe Pharma America (MTPA) and Soleo Health have entered into an agreement that will facilitate Soleo sharing…
Articles by Marisa Wexler, MS
Ibudilast Most Effective in People with Short History of ALS, Analysis Suggests
MediciNova‘s experimental therapeutic ibudilast (MN-166) may be most effective for treating amyotrophic lateral sclerosis (ALS)…
Exservan, Riluzole in Dissolving Oral Film Form, Approved by FDA
A dissolving oral film form of riluzole, called Exservan and able to be taken by amyotrophic lateral sclerosis (ALS)…
Phase 2 Trial Data on NurOwn Therapy, Supporting Safety And Early Efficacy, Published
NurOwn showed a good safety profile, as well as potential efficacy in a Phase 2 clinical trial that included people…
Exercise Helps to Slow Motor Neuron Loss in ALS, Study Suggests, But Type of Activity May Be Key
Exercise appears to benefit people with amyotrophic lateral sclerosis (ALS) by normalizing molecular changes that occur at the junction…
Canadian Health Professionals Recommend Stretching More, But Science Remains Shaky, Survey Finds
Health professionals in Canada are more likely to recommend stretching than strength or aerobic exercises to people with amyotrophic…
Mouse Study Uncovers Role of FUS Protein in ALS Neuromuscular Junction Defects
FUS protein plays a role in the proper functioning and stability of the neuromuscular junction — the site of communication…
Phase 2 CENTAUR Trial for AMX0035 Included Most Severe ALS Patients to Maximize Statistical Power, Experts Explain in Webinar
The Phase 2 CENTAUR trial testing AMX0035 for amyotrophic lateral sclerosis (ALS) was designed to include patients with…
Harvard Researcher Wins 2019 AANEM Scientific Impact Award for Study of Fingolimod in ALS
A Harvard Medical School professor and scientist, Sabrina Paganoni, has won the 2019 American Association of Neuromuscular and Electrodiagnostic Medicine…
Study Suggests Mechanism for ALS Caused by Toxic Algae-produced Compound
A toxin produced by algae may contribute to the development of amyotrophic lateral sclerosis (ALS) by lowering the stability…